Centerline Biomedical’s $33M in Series B equity financing

Centerline Biomedical, Inc., a private medical technology company, closed $33 million Series B equity financing, led by Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. This funding will help propel the company into new surgical applications, accelerate its commercial sales and add to its growing clinical evidence repository.

Cleveland Clinic led the financing with participation from GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures.

Cleveland Clinic, a non-profit academic medical center, provides clinical and hospital care and is a leader in research, education and health information.

The McDermott team was led by Krist Werling (Picture) and Aroma Sharma and included Mike Siekman. Global Legal Chronicle